BT
PFE icon

Beacon Trust’s Pfizer PFE Stock Holding History

Beacon Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$5.76M Buy
178,026
+1,119
+0.6% +$35.3K 0.91% 43
2016
Q4 		$5.45M Sell
176,907
-5,817
-3% -$178K 0.9% 44
2016
Q3 		$5.87M Sell
182,724
-4,220
-2% -$141K 0.98% 37
2016
Q2 		$6.25M Buy
186,944
+1,290
+0.7% +$41.2K 1.06% 32
2016
Q1 		$5.22M Buy
185,654
+855
+0.5% +$24.4K 0.91% 43
2015
Q4 		$5.66M Sell
184,799
-610
-0.3% -$19.2K 0.98% 32
2015
Q3 		$5.53M Sell
185,409
-7,266
-4% -$233K 0.97% 37
2015
Q2 		$6.13M Sell
192,675
-6,247
-3% -$204K 0.99% 35
2015
Q1 		$6.57M Sell
198,922
-4,553
-2% -$145K 1% 32
2014
Q4 		$6.01M Sell
203,475
-8,320
-4% -$239K 0.92% 40
2014
Q3 		$5.94M Sell
211,795
-2,570
-1% -$72.1K 0.98% 37
2014
Q2 		$6.04M Sell
214,365
-7,309
-3% -$208K 0.99% 42
2014
Q1 		$6.76M Sell
221,674
-30,825
-12% -$919K 1.15% 29
2013
Q4 		$7.34M Sell
252,499
-47,694
-16% -$1.39M 1.26% 25
2013
Q3 		$8.18M Sell
300,193
-135,591
-31% -$3.69M 1.51% 13
2013
Q2 		$11.6M Buy
+435,784
New +$12M 2.2% 6

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Beacon Trust's PFE Position: Q1 2017 in Review

Beacon Trust increased its Pfizer (PFE) stake by 0.63% in Q1 2017, buying an estimated $35.3K and bringing the position to 178,026 shares worth $5.76M. The position accounts for 0.91% of the portfolio, ranked #43.

Beacon Trust first reported a position in PFE in Q2 2013 and has held it in 16 quarters since. The position peaked at $11.6M in Q2 2013. 2,074 funds tracked by Wall St. Rank hold PFE as of Q1 2017.

  • Beacon Trust held 178,026 shares of Pfizer worth $5.76M as of Q1 2017.
  • Beacon Trust bought 1,119 Pfizer shares in Q1 2017, an estimated $35.3K.
  • Pfizer made up 0.91% of Beacon Trust's portfolio in Q1 2017, its #43 holding.
  • Beacon Trust first reported a position in Pfizer in Q2 2013 and has held it in 16 quarters since.
  • Beacon Trust's Pfizer position peaked at $11.6M in Q2 2013.
  • 2,074 funds tracked by Wall St. Rank held Pfizer as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.